NVCR
NVCR
NASDAQ · Health Care

Novocure Ltd

$17.12
+0.29 (+1.72%)
As of May 9, 1:37 AM ET ·
Financial Highlights (FY 2026)
Revenue
718.31M
Net Income
-149,316,492
Gross Margin
74.5%
Profit Margin
-20.8%
Rev Growth
+6.8%
D/E Ratio
0.57
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.5% 74.5% 51.4% 51.4%
Operating Margin -23.5% -21.1% 23.4% 21.7%
Profit Margin -20.8% -19.8% 17.5% 18.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 718.31M 672.51M 251.06M 253.67M
Gross Profit 535.43M 501.29M 129.14M 130.49M
Operating Income -168,587,344 -142,054,685 58.84M 55.04M
Net Income -149,316,492 -125,816,723 43.96M 45.64M
Gross Margin 74.5% 74.5% 51.4% 51.4%
Operating Margin -23.5% -21.1% 23.4% 21.7%
Profit Margin -20.8% -19.8% 17.5% 18.0%
Rev Growth +6.8% +6.8% -1.9% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 380.94M 380.94M 319.88M 342.35M
Total Equity 664.93M 664.93M 378.69M 362.47M
D/E Ratio 0.57 0.57 0.84 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -123,976,306 -110,268,224 70.91M 75.95M
Free Cash Flow 20.52M 25.20M